Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 6
2005 8
2006 4
2007 5
2008 8
2009 2
2010 4
2011 6
2012 11
2013 8
2014 8
2015 10
2016 10
2017 9
2018 7
2019 6
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

99 results
Results by year
Filters applied: . Clear all
Page 1
MerTK as a therapeutic target in glioblastoma.
Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, Ewend MG, Sulman EP, Gilbert MR, Earp HS, Miller CR. Wu J, et al. Among authors: Zamboni WC. Neuro Oncol. 2018 Jan 10;20(1):92-102. doi: 10.1093/neuonc/nox111. Neuro Oncol. 2018. PMID: 28605477 Free PMC article.
Factors Affecting the Pharmacology of Antibody-Drug Conjugates.
Lucas AT, Price LSL, Schorzman AN, Storrie M, Piscitelli JA, Razo J, Zamboni WC. Lucas AT, et al. Among authors: Zamboni WC. Antibodies (Basel). 2018 Feb 7;7(1):10. doi: 10.3390/antib7010010. Antibodies (Basel). 2018. PMID: 31544862 Free PMC article. Review.
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG.
McSweeney MD, Price LSL, Wessler T, Ciociola EC, Herity LB, Piscitelli JA, DeWalle AC, Harris TN, Chan AKP, Saw RS, Hu P, Jennette JC, Forest MG, Cao Y, Montgomery SA, Zamboni WC, Lai SK. McSweeney MD, et al. Among authors: Zamboni WC. J Control Release. 2019 Oct;311-312:138-146. doi: 10.1016/j.jconrel.2019.08.017. Epub 2019 Aug 24. J Control Release. 2019. PMID: 31454530
99 results
Jump to page
Feedback